NPPA and heart disorder: Consistent with its use as a surrogate marker of hypertrophy increased in patients with cardiac disease and in animal models of hypertrophy [36], [37], the expression of ANF mRNA and protein was also markedly upregulated following ET-1 exposure (Fig. 1D, Ei and Eii).